Rohtak man, 54, joins human trial of Covaxin after son

A fortnight after a 26-year-old man joined the human trials of Covaxin — the country’s foremost vaccine candidate for Covid-19 — at the Post-Graduate Institute of Medical Sciences (PGIMS) in Rohtak, his 54-year-old father, who is a government employee, also joined the trials on Thursday.